跳至主要内容
临床试验/CTRI/2026/01/100740
CTRI/2026/01/100740尚未招募不适用

A Single Arm Clinical Trial To Study The Effect Of Agnikarma With Suvarna Shalaka As An Ashukari Chikitsa In The Management Of Snayugata Vata With Special Reference To Lateral Epicondylitis.

Dr Saumya Suresh Mishra1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年1月30日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
the role of Agnikarma with Suvarna Shalaka as an Ashukari

研究概览

简要总结

**TITLE -**A SINGLE ARM CLINICAL TRIAL TO STUDY THE EFFECT OF AGNIKARMA WITH SUVARNA SHALAKA AS AN ASHUKARI CHIKITSA IN THE MANAGEMENT OF SNAYUGATA VATA WITH SPECIAL REFERENCE TO LATERAL EPICONDILYTIS.

**INTRODUCTION -**In Ayurveda, Snayugatavata is classified under Vatavyadhi. In this condition, the Vata Dosha becomes vitiated and localizes in the Snayu (ligaments and tendons) of the body. This results in symptoms such as Shoola (pain), Kampa (tremors), and Stambha (stiffness) in the Kurpara Sandhi (elbow joint). A similar condition in modern medicine is Lateral Epicondylitis, commonly known as Tennis Elbow. It occurs due to repetitive strain or excessive workload, leading to microtears or rupture of the tendon at the elbow joint, which causes pain and a reduced grip strength.

The prevalence of Lateral Epicondylitis is 3%. According to the Lakshanas we can correlate it to Snayugatavata and  lateral epicondylitis.

In modern science, there are two line of treatment for Tennis elbow which includes :

A) medicinal (steroids)

B) surgical

Therefore this study is selected for the research purpose, to avoid adverse reaction of long term use of steroids.

Gold has one of the highest thermal conductivity among metals. It delivers heat more uniformly and deeply into the affected tissues compared to other . And Suvarna Shalaka has yet not been studied for Agnikarma procedure in Snayugatavata as an Ashukari Chikitsa to fulfill this knowledge gap.  there is a need to study Agnikarma as an Ashukari Chikitsa in Snayugat Vata.

Vas scale will be applied for clinical study and final conclusion will be drawn.

Null Hypothesis(H0):  Agnikarma with Suvarna Shalaka is not effective as an Ashukari Chikitsa  in the management of Snayugatavata with special reference to lateral Epicondilytis.

Alternate Hypothesis(H1): Agnikarma with Suvarna Shalaka is effective as an Ashukari Chikitsa  in the management of Snayugatavata with special reference to lateral Epicondilytis.

**Size Sample:**The sample size was calculated by the formula and the prevalence rate of the disease. Hence the calculated sample size is 51, but for more accuracy of study sample size will be taken 60 patients.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • •Patients in the age group of 20 to 60 years of either sex.
  • •Patients will be included if they experience sign and symptoms of snayugatavata at Karpur Sandhi.
  • •Patients will be included by confirming positive cozens test and mills maneuver.

排除标准

  • •A patient will be excluded if he or she was currently receiving corticosteroid injection during the past months.
  • •Patients which are contraindicated for Agnikarma.
  • •Patients who have completed participation in any other clinical trial during last 6 months 4) Patient which are known cases of DM, IHD,HTN, Malignancies, Dyslipidemia, Chronic Renal Failure & Endochronological disorders will be excluded 5) Cervical spine or any other upper limb dysfuction.
  • •Neurological disease and osteoporosis.

结局指标

主要结局

the role of Agnikarma with Suvarna Shalaka as an Ashukari

时间窗: Within 1 Day of Treatment

Chikitsa in the management of Snayugata Vata with special reference to

时间窗: Within 1 Day of Treatment

lateral epicondylitis based on subjective and objective criteria

时间窗: Within 1 Day of Treatment

次要结局

未报告次要终点

研究者

发起方
Dr Saumya Suresh Mishra
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Saumya Suresh Mishra

SMBT Ayurved College and Hospital

研究点 (1)

Loading locations...

相似试验